Douglas N Martini1, Eline Zeeboer1, Andrea Hildebrand2, Brett W Fling3, Cinda L Hugos4, Michelle H Cameron5. 1. Department of Neurology, Oregon Health & Science University, Portland, OR. 2. Veterans Affairs Portland Health Care System, Portland, OR. 3. Department of Health and Exercise Science, Colorado State University, Fort Collins, CO. 4. Department of Neurology, Oregon Health & Science University, Portland, OR; Veterans Affairs Portland Health Care System, Portland, OR. 5. Department of Neurology, Oregon Health & Science University, Portland, OR; Veterans Affairs Portland Health Care System, Portland, OR. Electronic address: Michelle.cameron@va.gov.
Abstract
OBJECTIVE: To evaluate the effect of the Assistive Device Selection, Training and Education Program (ADSTEP) on falls and walking and sitting activity in people with multiple sclerosis (PwMS). DESIGN: Randomized controlled trial. SETTING:Veterans affairs medical center. PARTICIPANTS: PwMS (N=40) using a walking aid at baseline who had fallen in the previous year. INTERVENTIONS: Participants were randomly assigned to ADSTEP or control. ADSTEP had 6 weekly, 40-minute, 1-on-1 sessions with a physical therapist, starting with walking aid selection and fitting, followed by task-oriented progressive gait training. Control was usual medical care with the option of ADSTEP after the study. MAIN OUTCOME MEASURES: The following were assessed at baseline, intervention completion, and 3 months later: falls, timed Up and Go, timed 25-foot walk, 2-minute walk, Four Square Step Test, International Physical Activity Questionnaire, Quebec User Evaluation of Satisfaction with Assistive Technologies, Multiple Sclerosis Walking Scale-12, Activities-Specific Balance Confidence Scale, and Multiple Sclerosis Impact Scale-29. Effect on these outcomes was estimated by a 2-by-2 repeated measures general linear model. RESULTS: Fewer ADSTEP than control participants fell (χ2=3.96, P<.05. number needed to treat =3.3). Time spent sitting changed significantly differently with ADSTEP than with control from baseline to intervention completion (F=11.16, P=.002. ADSTEP: reduced 87.00±194.89min/d; control: increased 103.50±142.21min/d; d=0.88) and to 3-month follow-up (F=9.25, P=.004. ADSTEP: reduced 75.79±171.57min/d; control: increased 84.50±149.23min/d; d=0.79). ADSTEP yielded a moderate effect on time spent walking compared to control at 3-month follow-up (P>.05. ADSTEP 117.53±148.40min/d; control 46.43±58.55min/d; d=0.63). CONCLUSIONS:ADSTEP prevents falls, reduces sitting, and may increase walking in PwMS. Published by Elsevier Inc.
RCT Entities:
OBJECTIVE: To evaluate the effect of the Assistive Device Selection, Training and Education Program (ADSTEP) on falls and walking and sitting activity in people with multiple sclerosis (PwMS). DESIGN: Randomized controlled trial. SETTING: Veterans affairs medical center. PARTICIPANTS: PwMS (N=40) using a walking aid at baseline who had fallen in the previous year. INTERVENTIONS:Participants were randomly assigned to ADSTEP or control. ADSTEP had 6 weekly, 40-minute, 1-on-1 sessions with a physical therapist, starting with walking aid selection and fitting, followed by task-oriented progressive gait training. Control was usual medical care with the option of ADSTEP after the study. MAIN OUTCOME MEASURES: The following were assessed at baseline, intervention completion, and 3 months later: falls, timed Up and Go, timed 25-foot walk, 2-minute walk, Four Square Step Test, International Physical Activity Questionnaire, Quebec User Evaluation of Satisfaction with Assistive Technologies, Multiple Sclerosis Walking Scale-12, Activities-Specific Balance Confidence Scale, and Multiple Sclerosis Impact Scale-29. Effect on these outcomes was estimated by a 2-by-2 repeated measures general linear model. RESULTS: Fewer ADSTEP than control participants fell (χ2=3.96, P<.05. number needed to treat =3.3). Time spent sitting changed significantly differently with ADSTEP than with control from baseline to intervention completion (F=11.16, P=.002. ADSTEP: reduced 87.00±194.89min/d; control: increased 103.50±142.21min/d; d=0.88) and to 3-month follow-up (F=9.25, P=.004. ADSTEP: reduced 75.79±171.57min/d; control: increased 84.50±149.23min/d; d=0.79). ADSTEP yielded a moderate effect on time spent walking compared to control at 3-month follow-up (P>.05. ADSTEP 117.53±148.40min/d; control 46.43±58.55min/d; d=0.63). CONCLUSIONS: ADSTEP prevents falls, reduces sitting, and may increase walking in PwMS. Published by Elsevier Inc.
Authors: Hilary Gunn; Sophie Markevics; Bernhard Haas; Jonathan Marsden; Jennifer Freeman Journal: Arch Phys Med Rehabil Date: 2015-06-10 Impact factor: 3.966
Authors: Amit Kumar; Mark R Schmeler; Amol M Karmarkar; Diane M Collins; Rosemarie Cooper; Rory A Cooper; Hyekyoung Shin; Margo B Holm Journal: Disabil Rehabil Assist Technol Date: 2012-05-22
Authors: Rachel E Klaren; Robert W Motl; Deirdre Dlugonski; Brian M Sandroff; Lara A Pilutti Journal: Arch Phys Med Rehabil Date: 2013-07-29 Impact factor: 3.966
Authors: Joanne M Wagner; Rosemary A Norris; Linda R Van Dillen; Florian P Thomas; Robert T Naismith Journal: Int J Rehabil Res Date: 2013-09 Impact factor: 1.479
Authors: Brett W Fling; Douglas N Martini; Eline Zeeboer; Andrea Hildebrand; Michelle Cameron Journal: Mult Scler Relat Disord Date: 2019-03-08 Impact factor: 4.339
Authors: Meena Kannan; Andrea Hildebrand; Cinda L Hugos; Rouba Chahine; Gary Cutter; Michelle H Cameron Journal: Mult Scler Relat Disord Date: 2019-04-13 Impact factor: 4.339
Authors: Sara Hayes; Rose Galvin; Catriona Kennedy; Marcia Finlayson; Christopher McGuigan; Cathal D Walsh; Susan Coote Journal: Cochrane Database Syst Rev Date: 2019-11-28